Stockscreener 앱 받기
6.78
4.64%
-0.33
시간 외 거래:
6.78
전일 마감가:
$7.11
열려 있는:
$6.94
하루 거래량:
117.03K
Relative Volume:
0.72
시가총액:
$253.82M
수익:
$128.45M
순이익/손실:
$6.54M
주가수익비율:
135.60
EPS:
0.05
순현금흐름:
$-8.79M
1주 성능:
-1.74%
1개월 성능:
-2.87%
6개월 성능:
-7.00%
1년 성능:
+13.19%
1일 변동 폭
$6.67
$7.03
1주일 범위
$6.67
$7.37
52주 변동 폭
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(952) 368-4300
주소
3515 LYMAN BOULEVARD, CHASKA
LFCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.78 | 266.39M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | 개시 | William Blair | Outperform |
| 2024-09-05 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Should I hold or sell Lifecore Biomedical Inc. stock in 2025Layoff News & Safe Entry Zone Tips - newser.com
Is Lifecore Biomedical Inc. stock ready for breakoutJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
Will Lifecore Biomedical Inc. outperform the marketTrade Performance Summary & Low Drawdown Investment Ideas - newser.com
Will Lifecore Biomedical Inc. (LDE) stock benefit from infrastructure billJuly 2025 Levels & Risk Controlled Daily Plans - newser.com
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index fundsTrade Signal Summary & Technical Pattern Based Signals - newser.com
Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product - Contract Pharma
What candlestick patterns are forming on Lifecore Biomedical Inc.Bear Alert & Weekly High Potential Stock Alerts - newser.com
Market reaction to Lifecore Biomedical Inc.’s recent newsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
How Lifecore Biomedical Inc. stock benefits from strong dollarAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Will Lifecore Biomedical Inc. (LDE) stock recover faster than industryTrade Ideas & Expert Curated Trade Ideas - newser.com
What catalysts could drive Lifecore Biomedical Inc. stock higher2025 AllTime Highs & Safe Capital Growth Trade Ideas - newser.com
Is it too late to sell Lifecore Biomedical Inc.July 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
Can Lifecore Biomedical Inc. stock weather global recessionCPI Data & Advanced Technical Analysis Signals - newser.com
Is Lifecore Biomedical Inc. forming a reversal patternSell Signal & Safe Entry Point Identification - newser.com
Can Lifecore Biomedical Inc. stock beat market expectations this quarterJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Real time pattern detection on Lifecore Biomedical Inc. stockRate Cut & Long-Term Capital Growth Strategies - newser.com
Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Lifecore Biomedical Inc. stock affected by interest rate hikes2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
What hedge fund moves indicate for Lifecore Biomedical Inc. (LDE) stock2025 AllTime Highs & Daily Profit Focused Screening - newser.com
When is the best time to exit Lifecore Biomedical Inc.July 2025 Rallies & Low Drawdown Investment Strategies - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Key metrics from Lifecore Biomedical Inc.’s quarterly dataMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockMarket Activity Recap & Precise Buy Zone Tips - newser.com
Why millennials buy Lifecore Biomedical Inc. (LDE) stock2025 Sector Review & Safe Investment Capital Preservation Plans - newser.com
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulation2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com
Lifecore Biomedical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Lifecore Biomedical Approves Key Proposals at Annual Meeting - TipRanks
LFCR 2025 meeting: board elected, KPMG ratified, say-on-pay OK - Stock Titan
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.60%
0.45%
자본화:
|
볼륨(24시간):